Timeline

Voting rights breakdown

Notice details

Beneficial owner

Benjamin Levine

LMR Partners has entered into a lock-up agreement with Idorsia Ltd ("Idorsia"), Idorsia Pharmaceuticals Ltd and certain holders of Idorsia convertible bonds 2025 (ISIN CH0426820350) (the "CB2025") and/or Idorsia convertible bonds 2028 (ISIN CH1128004079) (the "CB2028") dated 25 February 2025 (the "Lock-Up Agreement") and is thus a member of the lock-up group initially disclosed on 3 March 2025. Thus this disclosure notification includes only the positions held by LMR Partners, which are not locked under the Lock-Up Agreement and, hence, are not covered by the lock-up group disclosure. Under the Lock-Up Agreement and a backstop letter agreement with Idorsia Ltd, Idorsia Pharmaceuticals Ltd and certain holders of CB2025 and/or CB2028, dated 25 February 2025 (the "Backstop Letter"; the Backstop Letter together with the Lock-Up Agreement, the "Agreements"), as of the date of this disclosure, LMR Partners holds the rights to receive: - 4,012,583 registered shares of Idorsia (the "Shares") as per different conditions and milestones events as defined in the Agreements up until Q3/2025, arrangement fee and exchange fee. The allocation of Shares under the arrangement fee and exchange fee is subject to changes before final delivery; - 3,743,650 warrants for Shares (with the terms as set forth below, the "Warrant") as per different conditions and milestones events as defined in the Agreements until Q3/2025, arrangement fee and exchange fee. The allocation of Warrants for the arrangement fee and exchange fee is subject to changes before final delivery. - date of transfer of equity securities (if different from date of the act which creates the obligation to notify): Expected in Q3 of 2025.